vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and National Storage Affiliates Trust (NSA). Click either name above to swap in a different company.
National Storage Affiliates Trust is the larger business by last-quarter revenue ($187.0M vs $180.9M, roughly 1.0× AVANOS MEDICAL, INC.). National Storage Affiliates Trust runs the higher net margin — 12.2% vs -0.7%, a 13.0% gap on every dollar of revenue. On growth, AVANOS MEDICAL, INC. posted the faster year-over-year revenue change (0.7% vs -1.6%). National Storage Affiliates Trust produced more free cash flow last quarter ($299.8M vs $21.3M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -2.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
National Storage Affiliates Trust is a U.S.-headquartered real estate investment trust focused on self-storage assets. It owns, operates and acquires self-storage facilities across dozens of U.S. states, offering secure storage solutions for residential and commercial customers.
AVNS vs NSA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $187.0M |
| Net Profit | $-1.3M | $22.9M |
| Gross Margin | 47.5% | 72.5% |
| Operating Margin | 1.4% | 20.2% |
| Net Margin | -0.7% | 12.2% |
| Revenue YoY | 0.7% | -1.6% |
| Net Profit YoY | 99.7% | 36.8% |
| EPS (diluted) | $-0.02 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $187.0M | ||
| Q3 25 | $177.8M | $188.7M | ||
| Q2 25 | $175.0M | $188.8M | ||
| Q1 25 | $167.5M | $188.4M | ||
| Q4 24 | $179.6M | $190.1M | ||
| Q3 24 | $170.4M | $193.6M | ||
| Q2 24 | $171.7M | $190.4M | ||
| Q1 24 | $166.1M | $196.1M |
| Q4 25 | $-1.3M | $22.9M | ||
| Q3 25 | $-1.4M | $18.4M | ||
| Q2 25 | $-76.8M | $19.5M | ||
| Q1 25 | $6.6M | $13.0M | ||
| Q4 24 | $-397.3M | $16.7M | ||
| Q3 24 | $4.3M | $18.7M | ||
| Q2 24 | $1.8M | $17.1M | ||
| Q1 24 | $-900.0K | $59.0M |
| Q4 25 | 47.5% | 72.5% | ||
| Q3 25 | 48.4% | 70.7% | ||
| Q2 25 | 52.6% | 70.5% | ||
| Q1 25 | 53.6% | 70.7% | ||
| Q4 24 | 54.6% | 72.5% | ||
| Q3 24 | 54.5% | 72.8% | ||
| Q2 24 | 55.7% | 72.6% | ||
| Q1 24 | 57.1% | 72.1% |
| Q4 25 | 1.4% | 20.2% | ||
| Q3 25 | 0.1% | 15.8% | ||
| Q2 25 | -42.6% | 16.5% | ||
| Q1 25 | 6.1% | 11.0% | ||
| Q4 24 | -233.0% | 14.5% | ||
| Q3 24 | 7.0% | 15.8% | ||
| Q2 24 | 3.7% | 17.2% | ||
| Q1 24 | 2.4% | 48.9% |
| Q4 25 | -0.7% | 12.2% | ||
| Q3 25 | -0.8% | 9.8% | ||
| Q2 25 | -43.9% | 10.3% | ||
| Q1 25 | 3.9% | 6.9% | ||
| Q4 24 | -221.2% | 8.8% | ||
| Q3 24 | 2.5% | 9.7% | ||
| Q2 24 | 1.0% | 9.0% | ||
| Q1 24 | -0.5% | 30.1% |
| Q4 25 | $-0.02 | $0.23 | ||
| Q3 25 | $-0.03 | $0.17 | ||
| Q2 25 | $-1.66 | $0.19 | ||
| Q1 25 | $0.14 | $0.10 | ||
| Q4 24 | $-8.64 | $0.19 | ||
| Q3 24 | $0.09 | $0.18 | ||
| Q2 24 | $0.04 | $0.16 | ||
| Q1 24 | $-0.02 | $0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $23.3M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $946.0M |
| Total Assets | $1.1B | $5.1B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $23.3M | ||
| Q3 25 | $70.5M | $26.3M | ||
| Q2 25 | $90.3M | $26.1M | ||
| Q1 25 | $97.0M | $19.3M | ||
| Q4 24 | $107.7M | $50.4M | ||
| Q3 24 | $89.0M | $69.9M | ||
| Q2 24 | $92.2M | $59.0M | ||
| Q1 24 | $75.8M | $64.2M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $946.0M | ||
| Q3 25 | $778.0M | $973.1M | ||
| Q2 25 | $776.3M | $1.0B | ||
| Q1 25 | $839.4M | $1.0B | ||
| Q4 24 | $828.5M | $1.1B | ||
| Q3 24 | $1.2B | $986.9M | ||
| Q2 24 | $1.2B | $1.2B | ||
| Q1 24 | $1.2B | $1.3B |
| Q4 25 | $1.1B | $5.1B | ||
| Q3 25 | $1.1B | $5.1B | ||
| Q2 25 | $1.0B | $5.2B | ||
| Q1 25 | $1.1B | $5.3B | ||
| Q4 24 | $1.2B | $5.4B | ||
| Q3 24 | $1.7B | $5.4B | ||
| Q2 24 | $1.7B | $5.3B | ||
| Q1 24 | $1.7B | $5.4B |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $338.5M |
| Free Cash FlowOCF − Capex | $21.3M | $299.8M |
| FCF MarginFCF / Revenue | 11.8% | 160.3% |
| Capex IntensityCapex / Revenue | 3.8% | 20.7% |
| Cash ConversionOCF / Net Profit | — | 14.79× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $541.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $338.5M | ||
| Q3 25 | $14.0M | $100.2M | ||
| Q2 25 | $6.8M | $79.9M | ||
| Q1 25 | $25.7M | $85.6M | ||
| Q4 24 | $57.9M | $363.1M | ||
| Q3 24 | $23.0M | $105.7M | ||
| Q2 24 | $27.8M | $83.2M | ||
| Q1 24 | $-8.0M | $94.0M |
| Q4 25 | $21.3M | $299.8M | ||
| Q3 25 | $7.0M | $88.0M | ||
| Q2 25 | $-4.2M | $73.8M | ||
| Q1 25 | $19.0M | $79.9M | ||
| Q4 24 | $53.1M | $344.4M | ||
| Q3 24 | $20.0M | $101.8M | ||
| Q2 24 | $21.9M | $79.5M | ||
| Q1 24 | $-12.1M | $88.6M |
| Q4 25 | 11.8% | 160.3% | ||
| Q3 25 | 3.9% | 46.6% | ||
| Q2 25 | -2.4% | 39.1% | ||
| Q1 25 | 11.3% | 42.4% | ||
| Q4 24 | 29.6% | 181.2% | ||
| Q3 24 | 11.7% | 52.6% | ||
| Q2 24 | 12.8% | 41.7% | ||
| Q1 24 | -7.3% | 45.2% |
| Q4 25 | 3.8% | 20.7% | ||
| Q3 25 | 3.9% | 6.5% | ||
| Q2 25 | 6.3% | 3.2% | ||
| Q1 25 | 4.0% | 3.0% | ||
| Q4 24 | 2.7% | 9.8% | ||
| Q3 24 | 1.8% | 2.0% | ||
| Q2 24 | 3.4% | 1.9% | ||
| Q1 24 | 2.5% | 2.7% |
| Q4 25 | — | 14.79× | ||
| Q3 25 | — | 5.44× | ||
| Q2 25 | — | 4.10× | ||
| Q1 25 | 3.89× | 6.59× | ||
| Q4 24 | — | 21.70× | ||
| Q3 24 | 5.35× | 5.65× | ||
| Q2 24 | 15.44× | 4.88× | ||
| Q1 24 | — | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
NSA
Segment breakdown not available.
